Hasan, Alkomiet
von Keller, Rupert
Friemel, Chris Maria
Hall, Wayne
Schneider, Miriam
Koethe, Dagmar
Leweke, F. Markus
Strube, Wolfgang
Hoch, Eva
Funding for this research was provided by:
Bundesgesundheitsministerium
Article History
Received: 26 September 2018
Accepted: 18 September 2019
First Online: 28 September 2019
Compliance with ethical standards
:
: AH was an advisory board member of Janssen-Cliag, Otsuka, Lundbeck and Roche and he was a speaker for Janssen-Cliag, Otsuka and Lundbeck. FML is a shareholder of curantis UG (ltd.) and has received research grants from the German Federal Ministry of Education and Research and Acerus Pharmaceuticals. EH received research grants from the German Federal Ministry of Health and the European Monitoring Centre for Drugs and Drug Addiction. She receives fees for trainings and a treatment manual for cannabis use disorders. WS received speakers fees by Mag & More. All other authors did not report a conflict of interest. All other authors did not report any conflicts of interest related to the content of this article.